Flow Cytometry Market - Databook 2025 to 2034

The global flow cytometry market size was evaluated at USD 5.71 billion in 2024 and is expected to grow around USD 12.02 billion by 2034, registering a CAGR of 7.72% from 2025 to 2034.

Highlights of the Flow Cytometry Market

• By product, the instruments segment underwent notable growth in the flow cytometry market during 2024.
• By product, the reagents & consumables segment will gain a significant share of the market over the studied period of 2025 to 2034.
• By technology, the cell-based segment enjoyed a prominent position in the flow cytometry market during 2024.
• By technology, the bead-based segment is predicted to witness significant growth in the market over the forecast period.
• By application, the research segment captured a significant portion of the flow cytometry market in 2024.
• By application, the clinical segment is projected to expand rapidly in the market in the coming years.
• By end-use, the universities segment maintained a leading position in the flow cytometry market in 2024.
• By end-use, the research institutions segment is anticipated to grow with the highest CAGR highest CAGR in the market during the studied years.
• By region, North America held the largest share of the flow cytometry market in 2024.
• By region, Asia Pacific is projected to host the fastest growing market in the coming years.

Industry Valuation and Growth Rate Projection

Flow cytometry is a technology that rapidly analyses single cells or particles as they flow past single or multiple lasers while suspended in a buffered salt-based solution. Each particle is analyzed for visible light scatter and one or multiple fluorescence parameters. The basic principle of flow cytometry is the passage of cells in single file in front of a laser so they can be detected, counted and sorted. Rising demand for point of care diagnostics, increase in the use of flow cytometry technologies in research activities, and technological advancements in flow cytometry instruments and reagents driving the growth of the flow cytometry market.

• According to a report published by World Cancer Research Fund, including non-melanoma skin cancer (NMSC) there were 19,976,499 cancer cases in 2022. When NMSC was excluded, this number is dropped to 18,741,966 cancer cases around the world in 2022. Of these, 9,566,825 were in men and 9,175,141 in women.

Flow Cytometry: Stats and Figures

According to a report published in February 2024 by World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases 9.7 million deaths. The estimated number of people who were allow within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, approximately 1 in 9 men and 1 in 12 women die from the disease.

• According to a report published by American Cancer Society in 2022, near about 20 million cancer cases were newly diagnosed and 9.7 million people died from the disease worldwide.

How AI Benefited the Flow Cytometry Market?

Artificial intelligence (AI) in imaging flow cytometry is used process the images or the time signal, generally to classify the particles/cells in two or more classes. AI in flow cytometry have been highly accurate and greatly reduce analysis variability compared to manual approaches. AI improves flow cytometry combines AI/ML algorithms with advanced analytics, allowing the interpretation of high dimensional data with unprecedented accuracy. Artificial intelligence and machine learning play an important role in data visualization and analysis.

Industry Leader Announcements

• Julie Sawyer Montgomery, Danaher Executive Vice President

Julie Sawyer Montgomery, Danaher Executive Vice President, said, “Precision medicines are more targeted than standard therapies and thus require precision diagnostics to determine which patients are most likely to benefit.” “We are excited to work with AstraZeneca on the goal of creating novel tests to increase access to precision medicines, helping ensure that no patients are left behind.”

• Jeff Porter, vice president of Marketing at Agilnet

Jeff Porter, vice president of Marketing at Agilent, said, “We are honored to receive these Scientists’ Choice awards from SelectScience and the scientific community.” “These recognitions reflect our commitment to empowering scientists with the tools and knowledge they need to drive discovery and innovation and bring great science to life.”

Geographical Insights

North America held the largest share of the flow cytometry market in 2024. Rising demand for point of care diagnostics, increase in use of floe cytometry technologies in research activities, and technological advancements in flow cytometry instruments and reagents driving the growth of the market in the North American region.

Asia Pacific is projected to host the fastest growing market in the coming years. Increasing awareness about the benefit of flow cytometry in diagnostics and research, growing demand for user friendly and automated flow cytometry systems in clinical laboratories, and increasing partnerships between industry players and academic institutions contributing to the growth of the flow cytometry market in the Asia Pacific region.

Recent Developments in the Flow Cytometry Market

• In May 2025, a latest innovation, the spectral enabled Invitrogen Attune Xenith Flow Cytometer was launched by Thermo Fischer Scientific TMO. The solution allows immune-oncology and immunology researchers to streamline and automate workflows to obtain more accurate and detailed insights from critical cellular samples.
• In March 2025, industry-first modular spectral flow cytometry solution- the CytoFLEX mosaic Spectral Detection Module was launched by Bechman Coulter Life Sciences, a global leader in laboratory automation and innovation, and Operating Company of Danaher Corporation.

Competitive Landscape

• Company Name: Danaher Corporation
• Year of Incorporation: 1984
• Headquarters: Washington, D.C., United States

Over 60 countries where it operates. It operates in the diagnostics, biotechnology, and life sciences sectors around the world.

• Company Name: Agilent Technologies, Inc.
• Year of Incorporation: 1999
• Headquarters: Santa Clara, California, United States

It operates in over 110 countries. It operates in the life sciences and healthcare sectors specially in research and diagnostics industry, around the world.